Transplantation Proceedings
Volume 31, Issue 3, Supplement 1 , Pages 2S-5S , May 1999

Generic immunosuppressant use in solid organ transplantation

  • R.R Alloway

      Affiliations

    • Department of Medicine, University of Tennessee, Memphis, Tennessee, USA
    • Department of Pharmacy, University of Tennessee, Memphis, Tennessee, USA
    • Corresponding Author InformationAddress reprint requests to Rita R. Alloway, PharmD, BCPS, Associate Professor of Pharmacy and Medicine, University of Tennessee, 951 Court Ave, Room B10B, Memphis, TN 38103

References 

  1. IMS Year-in-Review, 1997, Plymouth Group. IMS America, Ltd. 1998
  2. Strom BL. N Engl J Med. 1987;316:1456
  3. Levy G, Hall NA, Nelson E. J Pharm Sci. 1963;52:605
  4. Am J Hosp Pharm 21:402, 1964
  5. Elau SP. Arthitis Rheum. 1973;16:775
  6. Sullivan T, Hallmark M, Sakmar E, et al.  J Pharmacokinet Biopharm. 1976;4:157
  7. Meyer MC. Am J Managed Care. 1998;4:1183
  8. Azathioprine, Product Information, Roxanne Laboratories Inc, Columbus, Ohio
  9. Lake K, et al.  J Heart Lung Transplant. 1998;17:105
  10. Lee YJ, Chung SJ, Shim CK. Int J Clin Pharmacol Ther. 1998;36:210
  11. Schroeder TJ, Cho MJ, Pollack GM, et al.  J Clin Pharmacol. 1998;38:807
  12. First MR, Schroeder TJ, Alloway RR. Clin Transplant. 1998;12:518
  13. Fisher RA, Pan SH, Lopez R: Transplant Proc (in press)
  14. Alloway R, Canafax D, Schroeder T, et al.  Transplantation. 1998;65:S6
  15. Kovarik JM, Vernillet L, Mueller EA, et al.  Ther Drug Monit. 1994;16:519

PII: S0041-1345(99)00102-5

Transplantation Proceedings
Volume 31, Issue 3, Supplement 1 , Pages 2S-5S , May 1999